Clinical Profiles and Outcomes in Patients with Ulcerative Colitis Receiving Standard and Higher-Than-Standard Doses of Vedolizumab: Findings from a Real-World Study in Europe
AuthID
P-00Z-0E7
P-00Z-0E7